X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

Financial Daily Dose 8.3.2020 | Top Story: Microsoft in Talks to Acquire ByteDance’s U.S. TikTok Operations

Following recent histrionics from the White House, ByteDance, “the Chinese internet giant that owns...

Read More >

Delaware Court Addresses Meaning of “Affiliate”

In PWP Xerion Holdings III LLC v Red Leaf Resources, Inc. discussed disputed consent rights in conne...

Read More >

InterConnect FLASH! No. 79 - Mr. AB-5 Goes to Washington - And Brings A Lot of Baggage! (The Assault on the IC Citadel Continues)

Introduction: The PRO Act Overall - Early last week, the U.S. House of Representatives passed the ...

Read More >

Pennsylvania May Soon Require Employers To Disclose Pay Ranges To Applicants And Employees

The Pennsylvania House of Representatives recently introduced a bill that would amend the commonweal...

Read More >

Changing Workplaces, Changing Classifications: Increasing Relevance of the Dependent Contractor

The classification of workers has become an increasingly relevant consideration for both hirers and ...

Read More >

Regulatory Change to the EB-5 Immigrant Investor Program

U.S. Citizenship and Immigration Services (USCIS) announced on July 23, 2019 that final regulations ...

Read More >